We reached an important milestone in Q4 ahead of our prior expectations. During the quarter, a second customer adopted our AI ...

Q4 2025 Earnings Call March 29, 2026 7:00 AM EDTCompany ParticipantsKebin Dai - Chairman of the Board & CEOGe Tian ...

Total Operating Revenue (Q4) -- $102.4 million, up 8% versus prior-year quarter. Net Loss (Q4) -- $200,000, compared to a net ...

nCino, Inc. (NASDAQ:NCNO) Q4 2026 Earnings Call Transcript March 31, 2026 nCino, Inc. beats earnings expectations. Reported EPS is $0.37, expectations were $0.21. Operator: Good day, and thank you for ...

Q4 2025 Earnings Call April 9, 2026 5:00 PM EDTCompany ParticipantsJorge Flores - Chief Operating OfficerFawad Maqbool ...

Kingsoft Cloud Holdings Limited (NASDAQ:KC) Q4 2025 Earnings Call Transcript March 25, 2026 Kingsoft Cloud Holdings Limited ...

Potential Priority Review Vouchers (PRVs) -- The HLHS program holds rare pediatric disease designation, making Longeveron eligible for a PRV if approved; PDCM program could also achieve PRV ...

Origin Materials, Inc. (NASDAQ:ORGN) Q4 2025 Earnings Call Transcript March 27, 2026 Origin Materials, Inc. misses on ...

The Registrations for Google's Student Researcher 2026 program will conclude tomorrow, on March 31, 2026. Students enrolled in bachelor's, master's, or doctoral programs can apply via the Google ...

INmune Bio, Inc. (NASDAQ:INMB) Q4 2025 Earnings Call Transcript March 30, 2026 INmune Bio, Inc. beats earnings expectations.

Reported Revenue -- $71 million, reflecting a decrease due to accounting for Cespira as an equity method joint venture; ...

Five years after Pete Pearson, 75, was diagnosed with a terminal lung condition, he was experiencing debilitating anxiety and depression known as "end-of-life distress." He wanted to try psilocybin — ...